Abstract
It has been known that myriocin inhibits melanoma growth. However, the effects and action mechanisms of myriocin on lung cancer cell growth have not been reported. In this study, we examined whether myriocin isolated from Mycelia sterilia inhibits cell growth of lung cancer cells (A549 and NCI-H460) as well as possible signaling pathways involved in cell growth inhibition. Different concentrations of myriocin inhibited the growth of lung cancer cells through the induction of apoptotic cell death. Consistent with cancer cell growth inhibition, myriocin induced the expression of death receptors (DRs) as well as p-JNK and p-p38 in both cell lines. Moreover, the combination of myriocin with DR4 ligand TRAIL, and other well known anti-tumor drugs (docetaxel and cisplatin) synergistically inhibited cancer cell growth, and induced DR4 expression. These results showed that myriocin inhibits lung cancer cells growth through apoptosis via the activation of DR4 pathways, and enhanced anti-cancer effects with well known drugs. Thus, our study indicates that myriocin could be effective for lung cancer cells as an anti-cancer drug and/or a conjunction agent with well known anti-cancers.
Similar content being viewed by others
References
Abdollahi, T., N.M. Robertson, A. Abdollahi, and G. Litwack. 2005. Inhibition of TRAIL-induced apoptosis by IL-8 is mediated by the p38-MAPK pathway in OVCAR3 cells. Apoptosis an International Journal on Programmed Cell Death 10: 1383–1393.
Ban, J.O., H.S. Lee, H.S. Jeong, S. Song, B.Y. Hwang, D.C. Moon, Y. do Yoon, S.B. Han, and J.T. Hong. 2009. Thiacremonone augments chemotherapeutic agent-induced growth inhibition in human colon cancer cells through inactivation of nuclear factor-{kappa}B. Molecular Cancer Research MCR 7: 870–879.
Beadsmoore, C.J., and N.J. Screaton. 2003. Classification, staging and prognosis of lung cancer. European Journal of Radiology 45: 8–17.
Blenis, J. 1993. Signal transduction via the MAP kinases: Proceed at your own RSK. Proceedings of the National Academy of Sciences of the United States of America 90: 5889–5892.
Canals, D., D.M. Perry, R.W. Jenkins, and Y.A. Hannun. 2011. Drug targeting of sphingolipid metabolism: Sphingomyelinases and ceramidases. British Journal of Pharmacology 163: 694–712.
Debatin, K.M., D. Poncet, and G. Kroemer. 2002. Chemotherapy: Targeting the mitochondrial cell death pathway. Oncogene 21: 8786–8803.
Elrod, H.A., and S.Y. Sun. 2008. Modulation of death receptors by cancer therapeutic agents. Cancer Biology & Therapy 7: 163–173.
Hsin, Y.H., C.F. Chen, S. Huang, T.S. Shih, P.S. Lai, and P.J. Chueh. 2008. The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicology Letters 179: 130–139.
Ichite, N., M.B. Chougule, T. Jackson, S.V. Fulzele, S. Safe, and M. Singh. 2009. Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer. Clinical Cancer Research 15: 543–552.
Jin, C.Y., C. Park, G.Y. Kim, S.J. Lee, W.J. Kim, and Y.H. Choi. 2009. Genistein enhances TRAIL-induced apoptosis through inhibition of p38 MAPK signaling in human hepatocellular carcinoma Hep3B cells. Chemico-Biological Interactions 180: 143–150.
Jo, M., M.H. Park, P.S. Kollipara, B.J. An, H.S. Song, S.B. Han, J.H. Kim, M.J. Song, and J.T. Hong. 2012. Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway. Toxicology and Applied Pharmacology 258: 72–81.
Kakar, S.S., V.R. Jala, and M.Y. Fong. 2012. Synergistic cytotoxic action of cisplatin and withaferin A on ovarian cancer cell lines. Biochemical and Biophysical Research Communications 423: 819–825.
Kang, Y.J., I.Y. Kim, E.H. Kim, M.J. Yoon, S.U. Kim, T.K. Kwon, and K.S. Choi. 2011. Paxilline enhances TRAIL-mediated apoptosis of glioma cells via modulation of c-FLIP, survivin and DR5. Experimental & Molecular Medicine 43: 24–34.
Kerr, J.F., C.M. Winterford, and B.V. Harmon. 1994. Apoptosis. Its significance in cancer and cancer therapy. Cancer 73: 2013–2026.
Kim, E.J., S.Y. Park, J.Y. Lee, and J.H. Park. 2010a. Fucoidan present in brown algae induces apoptosis of human colon cancer cells. BMC Gastroenterology 10: 96.
Kim, S.M., S.Y. Lee, J.S. Cho, S.M. Son, S.S. Choi, Y.P. Yun, H.S. Yoo, do Y. Yoon, K.W. Oh, S.B. Han, et al. 2010b. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB. European Journal of Pharmacology 631: 1–9.
Kisim, A., H. Atmaca, B. Cakar, B. Karabulut, C. Sezgin, S. Uzunoglu, R. Uslu, and B. Karaca. 2012. Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels. Journal of Cancer Research and Clinical Oncology 138: 1155–1163.
Lee, Y.S., K.M. Choi, M.H. Choi, S.Y. Ji, S. Lee, D.M. Sin, K.W. Oh, Y.M. Lee, J.T. Hong, Y.P. Yun, et al. 2011. Serine palmitoyltransferase inhibitor myriocin induces growth inhibition of B16F10 melanoma cells through G(2)/M phase arrest. Cell Proliferation 44: 320–329.
Lee, Y.S., K.M. Choi, S. Lee, D.M. Sin, Y. Lim, Y.M. Lee, J.T. Hong, Y.P. Yun, and H.S. Yoo. 2012. Myriocin, a serine palmitoyltransferase inhibitor, suppresses tumor growth in a murine melanoma model by inhibiting de novo sphingolipid synthesis. Cancer Biology & Therapy 13: 92–100.
Li, J., and J. Yuan. 2008. Caspases in apoptosis and beyond. Oncogene 27: 6194–6206.
Liu, X., P. Yue, Z. Zhou, F.R. Khuri, and S.Y. Sun. 2004. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. Journal of the National Cancer Institute 96: 1769–1780.
Martinou, J.C., and R.J. Youle. 2011. Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Developmental Cell 21: 92–101.
Matsuo, K., Y.G. Lin, L.D. Roman, and A.K. Sood. 2010. Overcoming platinum resistance in ovarian carcinoma. Expert Opinion on Investigational Drugs 19: 1339–1354.
McFarland, D.C., and J.E. Pesall. 2008. Phospho-MAPK as a marker of myogenic satellite cell responsiveness to growth factors. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology 149: 463–467.
Medler, T.R., D.N. Petrusca, P.J. Lee, W.C. Hubbard, E.V. Berdyshev, J. Skirball, K. Kamocki, E. Schuchman, R.M. Tuder, and I. Petrache. 2008. Apoptotic sphingolipid signaling by ceramides in lung endothelial cells. American Journal of Respiratory Cell and Molecular Biology 38: 639–646.
Miyake, Y., Y. Kozutsumi, S. Nakamura, T. Fujita, and T. Kawasaki. 1995. Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin. Biochemical and Biophysical Research Communications 211: 396–403.
Moibi, J.A., A.L. Mak, B. Sun, and R.B. Moore. 2011. Urothelial cancer cell response to combination therapy of gemcitabine and TRAIL. International Journal of Oncology 39: 61–71.
Mou, H., Y. Zheng, P. Zhao, H. Bao, W. Fang, and N. Xu. 2011. Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas/FasL-mediated pathways. Toxicology In Vitro 25: 1027–1032.
O’Donovan, T.R., G.C. O’Sullivan, and S.L. McKenna. 2011. Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics. Autophagy 7: 509–524.
Ohtsuka, T., and T. Zhou. 2002. Bisindolylmaleimide VIII enhances DR5-mediated apoptosis through the MKK4/JNK/p38 kinase and the mitochondrial pathways. The Journal of Biological Chemistry 277: 29294–29303.
Ohtsuka, T., D. Buchsbaum, P. Oliver, S. Makhija, R. Kimberly, and T. Zhou. 2003. Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway. Oncogene 22: 2034–2044.
Ooi, A.T., V. Mah, D.W. Nickerson, J.L. Gilbert, V.L. Ha, A.E. Hegab, S. Horvath, M. Alavi, E.L. Maresh, D. Chia, et al. 2010. Presence of a putative tumor-initiating progenitor cell population predicts poor prognosis in smokers with non-small cell lung cancer. Cancer Research 70: 6639–6648.
Park, M.H., M.R. Jo, D. Won, H.S. Song, S.B. Han, M.J. Song, and J.T. Hong. 2012. Snake venom toxin from Vipera lebetina turanica induces apoptosis in colon cancer cells via upregulation of ROS- and JNK-mediated death receptor expression. BMC Cancer 12: 228.
Petrache, I., V. Natarajan, L. Zhen, T.R. Medler, A.T. Richter, C. Cho, W.C. Hubbard, E.V. Berdyshev, and R.M. Tuder. 2005. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nature Medicine 11: 491–498.
Ponnusamy, S., M. Meyers-Needham, C.E. Senkal, S.A. Saddoughi, D. Sentelle, S.P. Selvam, A. Salas, and B. Ogretmen. 2010. Sphingolipids and cancer: Ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. Future Oncology 6: 1603–1624.
Prasad, S., V.R. Yadav, R. Kannappan, and B.B. Aggarwal. 2011. Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-independent up-regulation of death receptors: evidence for the role of reactive oxygen species and JNK. The Journal of Biological Chemistry 286: 5546–5557.
Ramalingam, S., and C.P. Belani. 2004. State-of-the-art chemotherapy for advanced non-small cell lung cancer. Seminars in Oncology 31: 68–74.
Saddoughi, S.A., P. Song, and B. Ogretmen. 2008. Roles of bioactive sphingolipids in cancer biology and therapeutics. Sub-Cellular Biochemistry 49: 413–440.
Senthilkumar, K., P. Elumalai, R. Arunkumar, S. Banudevi, N.D. Gunadharini, G. Sharmila, K. Selvakumar, and J. Arunakaran. 2010. Quercetin regulates insulin like growth factor signaling and induces intrinsic and extrinsic pathway mediated apoptosis in androgen independent prostate cancer cells (PC-3). Molecular and Cellular Biochemistry 344: 173–184.
Shanker, A., A.D. Brooks, C.A. Tristan, J.W. Wine, P.J. Elliott, H. Yagita, K. Takeda, M.J. Smyth, W.J. Murphy, and T.J. Sayers. 2008. Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibody. Journal of the National Cancer Institute 100: 649–662.
Siddik, Z.H. 2002. Biochemical and molecular mechanisms of cisplatin resistance. Cancer Treatment and Research 112: 263–284.
Sun, Q., T. Chen, X. Wang, and X. Wei. 2010. Taxol induces paraptosis independent of both protein synthesis and MAPK pathway. Journal of Cellular Physiology 222: 421–432.
Sung, B., B. Park, V.R. Yadav, and B.B. Aggarwal. 2010. Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors. The Journal of Biological Chemistry 285: 11498–11507.
Taha, T.A., Y.A. Hannun, and L.M. Obeid. 2006. Sphingosine kinase: biochemical and cellular regulation and role in disease. Journal of Biochemistry and Molecular Biology 39: 113–131.
Tang, Y., X. Li, Z. Liu, A.R. Simoneau, J. Xie, and X. Zi. 2010. Flavokawain B, a kava chalcone, induces apoptosis via up-regulation of death-receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growth. International Journal of Cancer Journal International du Cancer 127: 1758–1768.
Vermeulen, K., D.R. Van Bockstaele, and Z.N. Berneman. 2005. Apoptosis: Mechanisms and relevance in cancer. Annals of Hematology 84: 627–639.
Wang, X., R. Lu, and J.Y. Fang. 2007. Effects of extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activation on proliferation and cell cycle associated genes in human colon cancer cells. Zhonghua Yi Xue Za Zhi 87: 982–986.
Weldon, C.B., A.P. Parker, D. Patten, S. Elliott, Y. Tang, D.E. Frigo, C.M. Dugan, E.L. Coakley, N.N. Butler, J.L. Clayton, et al. 2004. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling. International Journal of Oncology 24: 1473–1480.
Wu, N., C. Gu, H. Gu, H. Hu, Y. Han, and Q. Li. 2011. Metformin induces apoptosis of lung cancer cells through activating JNK/p38 MAPK pathway and GADD153. Neoplasma 58: 482–490.
Zhu, D.M., J. Shi, S. Liu, Y. Liu, and D. Zheng. 2011. HIV infection enhances TRAIL-induced cell death in macrophage by down-regulating decoy receptor expression and generation of reactive oxygen species. PLoS ONE 6: e18291.
Acknowledgments
This work was supported by the research grant of Chungbuk National University in 2012.
Conflict of interest
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Choi, K.E., Jung, Y.S., Kim, D.H. et al. Myriocin induces apoptotic lung cancer cell death via activation of DR4 pathway. Arch. Pharm. Res. 37, 501–511 (2014). https://doi.org/10.1007/s12272-013-0315-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-013-0315-z